These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

744 related articles for article (PubMed ID: 2859986)

  • 1. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor.
    Westendorf JM; Schonbrunn A
    Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocorticotropin, vasoactive intestinal polypeptide, growth hormone-releasing factor, and dynorphin compete for common receptors in brain and adrenal.
    Li ZG; Queen G; LaBella FS
    Endocrinology; 1990 Mar; 126(3):1327-33. PubMed ID: 1968378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin inhibits corticotropin-releasing factor-stimulated adrenocorticotropin release, adenylate cyclase, and activation of adenosine 3',5'-monophosphate-dependent protein kinase isoenzymes in AtT20 cells.
    Litvin Y; Leiser M; Fleischer N; Erlichman J
    Endocrinology; 1986 Aug; 119(2):737-45. PubMed ID: 2426087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing factor stimulates the release of adrenocorticotropin from domestic fowl pituitary cells.
    Carsia RV; Weber H; Perez FM
    Endocrinology; 1986 Jan; 118(1):143-8. PubMed ID: 3000730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin inhibits multireceptor stimulation of cyclic AMP formation and corticotropin secretion in mouse pituitary tumor cells.
    Heisler S; Reisine TD; Hook VY; Axelrod J
    Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6502-6. PubMed ID: 6128732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-mediated actions of growth hormone releasing factor on granulosa cell differentiation.
    Moretti C; Bagnato A; Solan N; Frajese G; Catt KJ
    Endocrinology; 1990 Nov; 127(5):2117-26. PubMed ID: 2171907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H; Tamura T
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of vasoactive intestinal peptide (VIP) and growth hormone releasing factor (GRF) with corticotropin releasing factor (CRF) on corticotropin secretion in vitro.
    Léonard JF; Bluet-Pajot MT; Oliver C; Kordon C
    Neuropeptides; 1988 Oct; 12(3):131-3. PubMed ID: 2853835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor.
    Birnbaum RS; Alfonzo M; Kowal J
    Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary corticotrope tumor (AtT20) cells as a model system for the study of early inhibition by glucocorticoids.
    Woods MD; Shipston MJ; Mullens EL; Antoni FA
    Endocrinology; 1992 Dec; 131(6):2873-80. PubMed ID: 1332850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor desensitization of adrenocorticotropic hormone release is augmented by arginine vasopressin.
    Hoffman AR; Ceda G; Reisine TD
    J Neurosci; 1985 Jan; 5(1):234-42. PubMed ID: 2981299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
    Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
    Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
    J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACTH secretion in mouse pituitary tumor cells in culture: inhibition of CRF-stimulated hormone release by somatostatin.
    Richardson UI
    Life Sci; 1983 Nov; 33(20):1981-8. PubMed ID: 6139727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of vasopressin and corticotropin-releasing hormone in VIP- and PHI-induced secretion of ACTH and corticosterone.
    Alexander LD; Sander LD
    Neuropeptides; 1995 Mar; 28(3):167-73. PubMed ID: 7791960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stimulatory effect of vasoactive intestinal peptides on the cortisol production of guinea pig Zona fasciculata cells: an extra-ACTH regulatory model of the adrenocortical function.
    Fang VS; Juan CC; Hsu YP; Won JG; Ho LT
    Chin J Physiol; 2001 Jun; 44(2):73-9. PubMed ID: 11530947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of corticotropin-releasing factor (CRF) receptors in the rat pituitary gland: effects of adrenalectomy on CRF receptors and corticotroph responses.
    Wynn PC; Harwood JP; Catt KJ; Aguilera G
    Endocrinology; 1985 Apr; 116(4):1653-9. PubMed ID: 2982594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of action of corticotropin-releasing factor and other regulators of corticotropin release in rat pituitary cells.
    Aguilera G; Harwood JP; Wilson JX; Morell J; Brown JH; Catt KJ
    J Biol Chem; 1983 Jul; 258(13):8039-45. PubMed ID: 6305967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of peptide histidine-isoleucine/vasoactive intestinal polypeptide-immunoreactive neurons in the central nervous system with special reference to their relation to corticotropin releasing factor- and enkephalin-like immunoreactivities in the paraventricular hypothalamic nucleus.
    Hökfelt T; Fahrenkrug J; Ju G; Ceccatelli S; Tsuruo Y; Meister B; Mutt V; Rundgren M; Brodin E; Terenius L
    Neuroscience; 1987 Dec; 23(3):827-57. PubMed ID: 3125490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.